Plasma Protein Therapeutics Market

Plasma Protein Therapeutics Market - Global Market Share, Trends, Analysis and Forecasts, 2023 - 2032
Frequently asked questions about this report

The plasma protein therapeutics market size is expected to reach US$ 41 Billion by 2032.

The plasma protein therapeutics market is expected grow at a CAGR of 5.6% from 2023 to 2032.

The plasma protein therapeutics market size was estimated to be US$ 24 Billion in 2022.

Key Plasma Protein Therapeutics market players are Baxter International Inc., Biotest Pharmaceuticals Corporation, China Biologic Products, Inc., CSL Behring, GRIFOLS, S.A, Kedrion S.p.A., Octapharma USA, Inc., Shire Plc. and others.

The increasing demand for plasma protein therapeutics for treatment of autoimmune neurologic diseases, acute cardiomyopathy, multifocal motor neuropathy (MMN), hemolytic disease of the newborn, autoimmune mucocutaneous blistering diseases, and acute panautonomic polyneuropathy is the prime factor towards the growth of the global plasma protein therapeutics market.

North America is the principal contributor to the global Plasma Protein Therapeutics market.

Based on type, the Plasma Protein Therapeutics market is segmented intoimmunoglobulin, albumin, plasma derived factor VIII, and others..